{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11259041", "DateCompleted": {"Year": "2001", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "26"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1523-7060", "JournalIssue": {"Volume": "3", "Issue": "5", "PubDate": {"Year": "2001", "Month": "Mar", "Day": "08"}}, "Title": "Organic letters", "ISOAbbreviation": "Org Lett"}, "ArticleTitle": "An approach to the skeleton of the securinega alkaloids. The total synthesis of (+/-)-securinine.", "Pagination": {"StartPage": "703", "EndPage": "706", "MedlinePgn": "703-6"}, "Abstract": {"AbstractText": ["[structure: see text]. The concise total synthesis of securinine in nine steps from readily available starting materials is described. Key steps of the synthesis include an addition of a silyloxyfuran to an in situ generated iminium ion and a novel ring closing metathesis reaction."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pfizer Global Research and Development, Groton, Connecticut 06340, USA. spiros_liras@groton.pfizer.com"}], "Identifier": [], "LastName": "Liras", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Davoren", "ForeName": "J E", "Initials": "JE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bordner", "ForeName": "J", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Org Lett", "NlmUniqueID": "100890393", "ISSNLinking": "1523-7052"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Azepines"}, {"RegistryNumber": "0", "NameOfSubstance": "Central Nervous System Stimulants"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, 4 or More Rings"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, Bridged-Ring"}, {"RegistryNumber": "0", "NameOfSubstance": "Indicators and Reagents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "G4VS580P5E", "NameOfSubstance": "securinine"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Azepines"}, {"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "Central Nervous System Stimulants"}, {"QualifierName": [], "DescriptorName": "Crystallization"}, {"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "GABA Antagonists"}, {"QualifierName": [], "DescriptorName": "Heterocyclic Compounds, 4 or More Rings"}, {"QualifierName": [], "DescriptorName": "Heterocyclic Compounds, Bridged-Ring"}, {"QualifierName": [], "DescriptorName": "Indicators and Reagents"}, {"QualifierName": [], "DescriptorName": "Lactones"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Piperidines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "3", "Day": "22", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "6", "Day": "8", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "3", "Day": "22", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11259041", "10.1021/ol0070482", "ol0070482"]}}], "PubmedBookArticle": []}